Showing results (211-220 of 391) with videos related to
Sort By:
Pageof 40
Bioorganic & Medicinal Chemistry|November 17, 2023
In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocketYanying Sun, Da Feng, Zhenzhen Zhou, et al.Drug Discovery Today|May 17, 2023
Targeting hepatitis B virus cccDNA levels: Recent progress in seeking small molecule drug candidatesYu Jin, Shuo Wang, Shujing Xu, et al.Acta Pharmaceutica Sinica. B|March 15, 2024
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variantsZhao Wang, Heng Zhang, Zhen Gao, et al.European Journal of Medicinal Chemistry|July 17, 2026
Dual prodrugs of N4-hydroxycytidine with ProTide and ester modifications as anti-SARS-CoV-2 agentsYe Li, Wenbo Zhang, Ni Gao, et al.Frontiers in Microbiology|April 8, 2020
Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase InhibitorsPing Li, Ruikun Du, Yanyan Wang, et al.Environmental Research|January 19, 2025
Untangling the impacts of bacterial community on carbon dioxide and nitrous oxide across a drinking water reservoirJiawen Wang, Shanqing Yang, Jiarui Li, et al.ACS Pharmacology & Translational Science|December 14, 2023
Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein InhibitorPing Li, Han Ju, Yihong Xing, et al.Acta Pharmaceutica Sinica. B|July 18, 2022
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteinsLingxin Hou, Ying Zhang, Han Ju, et al.Chemical Biology & Drug Design|March 3, 2019
Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed regionJi Yu, Haiyong Jia, Xiaowei Guo, et al.RSC Medicinal Chemistry|November 17, 2023
Discovery of carboxyl-containing heteroaryldihydropyrimidine derivatives as novel HBV capsid assembly modulators with significantly improved metabolic stabilityShujie Zhao, Ya Wang, Xujie Zhang, et al.Pageof 40